The GO enrichment revealed that osteonecrosis development was related with the change in extracellular matrix, external encapsulating structure organization, skeletal system development, and cellular development in GSE7116 and immune response activity, cell apoptosis, mononuclear cell differentiation, and serine/threonine kinase activity (Figure 4). The gene discussed is MARK2; the disease is osteonecrosis.